T-cell interferon-γ release assays: can we do better?

Lalvani A., Millington K. A.

Source: Eur Respir J 2008; 32: 1428-1430
Journal Issue: December

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Lalvani A., Millington K. A.. T-cell interferon-γ release assays: can we do better?. Eur Respir J 2008; 32: 1428-1430

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interferon-γ release assays for the diagnosis of active tuberculosis: sensible or silly?
Source: Eur Respir J 2009; 33: 1250-1253
Year: 2009


Interferon-γ release assay tests to rule out active tuberculosis
Source: Eur Respir J 2007; 30: 183-184
Year: 2007


Indeterminate results of a tuberculosis-specific interferon-γ release assay in immunocompromised patients
Source: Eur Respir J 2010; 35: 1179-1182
Year: 2010


Interferon gamma release assays in screening for tuberculosis – Can we use them in patients with sarcoidosis?
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011

Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis
Source: Eur Respir J 2007; 30: 722-728
Year: 2007



Treg cells are expanded among bronchoalveolar lymphocytes in healthy tuberculosis contacts with positive interferon-γ release assay responses
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011


Combination of interferon-γ and non-interferon-γ cytokines in tuberculosis specific cytokine release assays (TUCRA)
Source: Annual Congress 2010 - Tuberculosis: from bench to bedside
Year: 2010

Interferon-gamma release assays in tuberculosis contacts: is there a window period?
Source: Eur Respir J 2011; 37: 215-217
Year: 2011


Can we predict who will develop TB among those with a positive interferon-? release assay (IGRA)?
Source: International Congress 2018 – Important changes in the management of tuberculosis
Year: 2018


Time interval to conversion of interferon-? release assay after exposure to tuberculosis
Source: Eur Respir J 2011; 37: 1447-1452
Year: 2011



Comprehensive characterisation of T helper cells, cytotoxic T cells and novel invariant T cell phenotypes in human asthma
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013


Regulation of interleukin-1β and interleukin-1β inhibitor release by human airway epithelial cells
Source: Eur Respir J 2004; 24: 360-366
Year: 2004



Use of a T-cell interferon-γ release assay for the diagnosis of tuberculous pleurisy
Source: Eur Respir J 2007; 30: 1173-1179
Year: 2007



Indeterminate IFN-? release assay test results predict poor prognosis of active pulmonary tuberculosis
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019


Sarcoidosis following specific immunotherapy - more than just coincidence!
Source: Eur Respir J 2005; 26: Suppl. 49, 33s
Year: 2005

HLA-DP-unrestricted TNF-α release in beryllium-stimulated peripheral blood mononuclear cells
Source: Eur Respir J 2002; 20: 1174-1178
Year: 2002



Cytotoxic T cell antigen 4 and the status of T cell activation in lung cancer: local vs. systemic immune response.
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017



Late Breaking Abstract - Characterization of the immunological profile of COVID-19 patients and correlation of CD4+ and CD8+ T lymphocytes with disease severity during hospitalization.
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021



Discordance between TSTs and IFN-γ release assays: the role of NTM and the relevance of mycobacterial sensitins
Source: Eur Respir J 2010; 36: 215-216
Year: 2010